[go: up one dir, main page]

AU2001294459A1 - A controlled-release, parenterally administrable microparticle preparation - Google Patents

A controlled-release, parenterally administrable microparticle preparation

Info

Publication number
AU2001294459A1
AU2001294459A1 AU2001294459A AU9445901A AU2001294459A1 AU 2001294459 A1 AU2001294459 A1 AU 2001294459A1 AU 2001294459 A AU2001294459 A AU 2001294459A AU 9445901 A AU9445901 A AU 9445901A AU 2001294459 A1 AU2001294459 A1 AU 2001294459A1
Authority
AU
Australia
Prior art keywords
release
controlled
parenterally administrable
microparticle preparation
curve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294459A
Inventor
Soren Bjorn
Jorn Drustrup
Nils Ove Gustafsson
Monica Jonsson
Timo Laakso
Mats Reslow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Bioglan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003614A external-priority patent/SE517610C2/en
Application filed by Bioglan AB filed Critical Bioglan AB
Publication of AU2001294459A1 publication Critical patent/AU2001294459A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A parenterally administrable, biodegradable microparticle preparation containing a biologically active substance which, during the first 24 hours after injection, exhibits a release of the active substance that is less than 25% of the total release, determined from a concentration-time curve in the form of the ratio between the area under the curve during the said first 24 hours and the total area under the curve in question
AU2001294459A 2000-10-06 2001-10-05 A controlled-release, parenterally administrable microparticle preparation Abandoned AU2001294459A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0003614 2000-10-06
SE0003614A SE517610C2 (en) 2000-10-06 2000-10-06 New parenterally administrable microparticle preparation useful for controlled-release of biologically active substances e.g. drug
US26049501P 2001-01-08 2001-01-08
US60260495 2001-01-08
PCT/SE2001/002165 WO2002028375A1 (en) 2000-10-06 2001-10-05 A controlled-release, parenterally administrable microparticle preparation

Publications (1)

Publication Number Publication Date
AU2001294459A1 true AU2001294459A1 (en) 2002-04-15

Family

ID=26655254

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294459A Abandoned AU2001294459A1 (en) 2000-10-06 2001-10-05 A controlled-release, parenterally administrable microparticle preparation

Country Status (8)

Country Link
US (1) US7033609B2 (en)
EP (1) EP1328258B1 (en)
JP (1) JP2004510730A (en)
AT (1) ATE409465T1 (en)
AU (1) AU2001294459A1 (en)
CA (1) CA2424896A1 (en)
DE (1) DE60136002D1 (en)
WO (1) WO2002028375A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
FR2861734B1 (en) 2003-04-10 2006-04-14 Corneal Ind CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
EP1726299A3 (en) * 2005-05-27 2007-04-18 StratoSphere Pharma AB Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
US20090022808A1 (en) * 2007-05-23 2009-01-22 Allergan, Inc. Coated Hyaluronic Acid Particles
BRPI0811784A2 (en) * 2007-05-23 2011-05-10 Allergan Inc cross-linked collagen and use thereof
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) * 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
BRPI0819075A2 (en) 2007-11-16 2014-10-07 Vicept Therapeutics Inc METHOD FOR TREATING PURPOSE IN AN INDIVIDUAL AND METHOD FOR REDUCING PURPOSE IN AN INDIVIDUAL BEFORE SURGICAL PROCEDURE
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2658609T3 (en) 2008-09-02 2018-03-12 Tautona Group Lp Threads of hyaluronic acid and / or derivatives thereof, methods for manufacturing them, and uses thereof
CN101574638B (en) * 2009-06-15 2012-04-18 中国农业大学 Starch nano-microsphere and preparation method thereof
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US20130052647A1 (en) * 2010-02-10 2013-02-28 Marianna Goldrick Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery
JP5749283B2 (en) * 2010-03-12 2015-07-15 アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｉｎｄｕｓｔｒｉｅ Ｓａｓ Fluid composition for improving skin condition
ES2585388T5 (en) 2010-03-22 2019-08-08 Allergan Inc Crosslinked polysaccharide and protein polysaccharide hydrogels for soft tissue augmentation
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
CN107412002A (en) 2011-06-03 2017-12-01 阿勒根公司 Dermal filler composition including antioxidant
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US10722444B2 (en) 2014-09-30 2020-07-28 Allergan Industrie, Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
US20180236129A1 (en) 2015-02-13 2018-08-23 Allergan Industrie, Sas Implants for sculpting, augmenting or correcting facial features such as the chin

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE744162A (en) 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd ENCAPSULATION PROCESS
US3881991A (en) 1969-01-24 1975-05-06 Hayashibara Co Process for producing amylose powders having a mean degree of polymerization between 20{14 30
DE2010115A1 (en) 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Process for the production of micro-granules
US4389330A (en) 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4713249A (en) 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
SE459005B (en) 1985-07-12 1989-05-29 Aake Rikard Lindahl SET TO MANUFACTURE SPHERICAL POLYMER PARTICLES
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JP2670680B2 (en) 1988-02-24 1997-10-29 株式会社ビーエムジー Polylactic acid microspheres containing physiologically active substance and method for producing the same
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
AU5741590A (en) 1989-05-04 1990-11-29 Southern Research Institute Improved encapsulation process and products therefrom
DK168790D0 (en) 1990-07-13 1990-07-13 Novo Nordisk As
KR100259989B1 (en) 1991-10-01 2000-08-01 모리다 가쓰라 Sustained release microcapsules formulation and preparation method thereof
WO1993015722A1 (en) 1992-02-07 1993-08-19 Syntex (Usa) Inc. Controlled delivery of pharmaceuticals from preformed porous microparticles
AU4109493A (en) 1992-04-20 1993-11-18 Bruce K. Redding Jr. Method and apparatus for the modification of starch and other polymers
ATE195652T1 (en) 1992-12-02 2000-09-15 Alkermes Inc CONTROLLED RELEASE MICROSPHERES CONTAINING GROWTH HORMONE
DE69408527T2 (en) 1993-03-09 1998-06-04 Epic Therapeutics, Inc., Norwood, Mass. MACROMOLECULAR MICROPARTICLES AND METHOD FOR THE PRODUCTION THEREOF
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
DE4434877A1 (en) 1994-09-29 1996-04-04 Fresenius Ag Process for the production of starch breakdown products
KR100201352B1 (en) 1995-03-16 1999-06-15 성재갑 Single injection vaccine formulation
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
SE505146C2 (en) * 1995-10-19 1997-06-30 Biogram Ab Particles for delayed release
US5959102A (en) 1997-06-30 1999-09-28 Rutgers University Starch purification by thermally tolerant broad pH range proteolytic enzymes
SE512663C2 (en) 1997-10-23 2000-04-17 Biogram Ab Active substance encapsulation process in a biodegradable polymer
JPH11302156A (en) 1998-04-16 1999-11-02 Tanabe Seiyaku Co Ltd Method for micronizing polypeptide
SE517422C2 (en) * 2000-10-06 2002-06-04 Bioglan Ab Production of starch for parenteral administration in form of microparticles, comprises washing starch, dissolving in aqueous medium, and subjecting to molecular weight reduction by shearing

Also Published As

Publication number Publication date
DE60136002D1 (en) 2008-11-13
EP1328258B1 (en) 2008-10-01
JP2004510730A (en) 2004-04-08
ATE409465T1 (en) 2008-10-15
EP1328258A1 (en) 2003-07-23
CA2424896A1 (en) 2002-04-11
US7033609B2 (en) 2006-04-25
US20020102311A1 (en) 2002-08-01
WO2002028375A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2001294459A1 (en) A controlled-release, parenterally administrable microparticle preparation
MY118835A (en) Sustained release compositions and the process for their preparation
AU8142594A (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
AU8178601A (en) Sustained release pharmaceutical compositions for the parenteral administration of biologically active hydrophilic compounds
CA2207286A1 (en) Localized delivery of factors enhancing survival of transplanted cells
BR9916053B1 (en) compositions containing a peptide and a polylactic glycolic acid suitable for preparation of prolonged release subcutaneous implants.
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
HK33294A (en) Sustained release pharmaceutical compositions and the preparation of particles for use therein
MY113488A (en) Compounds with growth hormone releasing properties
CA2427815A1 (en) Controlled release hydrocodone formulations
CA2338358A1 (en) Compounds and compositions for delivering active agents
EP0864326A3 (en) Multiphasic preparation comprising an active agent
SG83819A1 (en) Copolymers having nitrile and alicyclic leaving groups and photoresist compositions comprising same
EP2269642A3 (en) Hcv vaccine compositions
EP1516615A3 (en) Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
MY116578A (en) Stable freeze-dried pharmaceutical formulation
MX9701465A (en) Acetaminophen sustained-release formulation.
EP1693054A3 (en) Lactic acid polymer and process for producing the same
CA2360220A1 (en) Oxadiazole compounds and compositions for delivering active agents
CA2358773A1 (en) Improved controlled release compositions and method
IL115138A0 (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
EP0950404A3 (en) Process for preparation of solid dosage forms
WO2002064093A3 (en) Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
EP0958835A4 (en) Preventive/remedy for frequent urination and urinary incontinence
WO2001066668A3 (en) Soil additive in the form of a coating